Malignant tumor of pancreas (disorder)
Clinical Trial: SPARC
Year Started: 2015
A phase 1 trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Followup records | 0 - 3 months |
| Imaging data | 0 - 3 months |
| Pathology records | 0 - 3 months |
| Physiological/biochemical measurements | 0 - 3 months |
| Treatment records | 0 - 3 months |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Barrett's esophagus (disorder)
Clinical Trial: AspECT
Year Started: 2005
AspECT: A Phase III, Randomised Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia. Trial has 10-year follow up period with samples collected throughout. Patient age groups given in the Sample Sets are the age of the patients at trial randomisation
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- Commercial restriction, DNA restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Followup records | 0 - 3 months |
| Pathology records | 3 - 6 months |
| Physiological/biochemical measurements | 0 - 3 months |
| Treatment records | 0 - 3 months |
Male
Adult (> 40 years)
1001 - 3000 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Male
Young adult (18 - 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Female
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Female
Young adult (18 - 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Malignant tumor of ovary (disorder)
Clinical Trial: 6MP
Year Started: 2011
See clinicaltrials.gov record NCT01432145 for more information about the study. Whole blood and plasma samples collected pre and post treatment in approx 70 participants and associated FFPE tumour tissue for approx 25 participants. Study data also available on request.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Tissue specimen | Surgical procedure (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Malignant tumor of ovary (disorder)
Clinical Trial: OCTOVA
Year Started: 2017
See ClinicalTrials.gov reference NCT03117933 for more information about the study. Whole blood and plasma samples pre and post-treatment with i.PARPi ii. control or iii. PARPi & anti-angiogenic. FFPE diagnostoc tumour sample.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Tissue specimen | Surgical procedure (procedure) | RT | N/A | Affected | 0 - 10% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Malignant tumor of rectum (disorder)
Clinical Trial: CEDAR
Year Started: 2019
A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% | ||
| Faeces | RT | Not applicable | 0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% |